1. Home
  2. ARCT vs LAAC Comparison

ARCT vs LAAC Comparison

Compare ARCT & LAAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • LAAC
  • Stock Information
  • Founded
  • ARCT 2013
  • LAAC 2007
  • Country
  • ARCT United States
  • LAAC Canada
  • Employees
  • ARCT N/A
  • LAAC N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • LAAC
  • Sector
  • ARCT Health Care
  • LAAC
  • Exchange
  • ARCT Nasdaq
  • LAAC Nasdaq
  • Market Cap
  • ARCT 487.0M
  • LAAC 490.6M
  • IPO Year
  • ARCT N/A
  • LAAC N/A
  • Fundamental
  • Price
  • ARCT $16.79
  • LAAC $2.98
  • Analyst Decision
  • ARCT Strong Buy
  • LAAC Buy
  • Analyst Count
  • ARCT 7
  • LAAC 2
  • Target Price
  • ARCT $65.00
  • LAAC $5.13
  • AVG Volume (30 Days)
  • ARCT 400.9K
  • LAAC 1.1M
  • Earning Date
  • ARCT 03-06-2025
  • LAAC 11-05-2024
  • Dividend Yield
  • ARCT N/A
  • LAAC N/A
  • EPS Growth
  • ARCT N/A
  • LAAC 3133.17
  • EPS
  • ARCT N/A
  • LAAC 7.78
  • Revenue
  • ARCT $160,399,000.00
  • LAAC N/A
  • Revenue This Year
  • ARCT $7.33
  • LAAC N/A
  • Revenue Next Year
  • ARCT $4.71
  • LAAC $208.49
  • P/E Ratio
  • ARCT N/A
  • LAAC $0.39
  • Revenue Growth
  • ARCT N/A
  • LAAC N/A
  • 52 Week Low
  • ARCT $14.30
  • LAAC $2.07
  • 52 Week High
  • ARCT $45.00
  • LAAC $5.79
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 46.15
  • LAAC 54.84
  • Support Level
  • ARCT $16.07
  • LAAC $2.78
  • Resistance Level
  • ARCT $17.95
  • LAAC $3.04
  • Average True Range (ATR)
  • ARCT 1.36
  • LAAC 0.13
  • MACD
  • ARCT -0.07
  • LAAC 0.04
  • Stochastic Oscillator
  • ARCT 14.86
  • LAAC 77.87

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.

About LAAC Lithium Americas (Argentina) Corp.

Lithium Argentina is a pure-play lithium producer. The company owns two neighboring lithium brine resources in northwest Argentina: Cauchari-Olaroz and Pastos Grandes. Cauchari-Olaroz entered production in 2023, while Pastos Grandes is still in development. Lithium Argentina plans for both resources to be fully integrated with onside downstream processing capabilities and will sell into the lithium chemical market.

Share on Social Networks: